Origin of leukemic relapse after bone marrow transplantation detected by restriction fragment length polymorphism.
Bone marrow transplantation has become an accepted modality in the treatment of acute leukemia. With this therapy, it is possible to obtain long-term disease-free survival. However, leukemia recurs occasionally. In most cases, leukemic relapse is of recipient origin. There have been several reports, though, of leukemia developing in donor cells. These cases have been limited to instances in which there is an easily identifiable chromosome difference or abnormality, usually a sex chromosome. In this paper we describe the use of restriction fragment-length polymorphism analysis to determine the origin of recurrent leukemia cells in which no identifying chromosome was present. We found that the leukemia had recurred in recipient cells. We also were able to demonstrate the presence of normal hemopoietic cells of donor origin.
Minden
M D
MD
Messner
H A
HA
Belch
A
A
D000328:Adult; D016026:Bone Marrow Transplantation; D002869:Chromosome Aberrations; D002874:Chromosome Mapping; D003582:Cytogenetics; D004247:DNA / Q000032:analysis; D004262:DNA Restriction Enzymes / Q000235:genetics / Q000378:metabolism; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000473:pathology / Q000628:therapy*; D008297:Male; D011110:Polymorphism, Genetic; D012397:Rosette Formation
D004247:DNA; D004262:DNA Restriction Enzymes